Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

ctHPVDNA in HPV-positive squamous cell carcinoma of the oropharynx

Interventional study in which people with undetectable postoperative circulating tumor HPV DNA and four or fewer nodes are assigned to observation without further adjuvant treatment. The registry lists the phase as not applicable and the primary outcome as disease-free survival. ClinicalTrials.gov lists the study as recruiting.

Indiana University